Home › Companies › ARROWHEAD PHARMACEUTICALS INC. › 2024-2025
Compiled from SEC Form N-PX filings and ARROWHEAD PHARMACEUTICALS INC.’s Form 8-K, filed 2025-03-19 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore ARROWHEAD PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are ARROWHEAD PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-03-19 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Christopher Anzalone | 78,346,448 | 4,406,009 | 117,717 | -- | -- | Majority: yes |
| Elect Director: William Waddill | 74,963,684 | 7,769,128 | 137,362 | -- | -- | Majority: yes |
| Elect Director: Michael Perry | 80,137,421 | 2,594,224 | 138,529 | -- | -- | Majority: yes |
| Elect Director: Victoria Vakiener | 80,629,562 | 2,087,405 | 153,207 | -- | -- | Majority: yes |
| Elect Director: Mauro Ferrari | 80,079,870 | 2,649,068 | 141,236 | -- | -- | Majority: yes |
| Elect Director: Adeoye Olukoton | 80,519,828 | 2,219,988 | 130,358 | -- | -- | Majority: yes |
| Elect Director: Hongbo Lu | 81,171,464 | 1,552,680 | 146,030 | -- | -- | Majority: yes |
| Elect Director: Douglas Ingram | 68,899,124 | 13,843,071 | 127,979 | -- | -- | Majority: yes |
Source: ARROWHEAD PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2025-03-19 — read the filing on EDGAR.
Each item below shows how the 289 asset managers that disclosed a ARROWHEAD PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ARROWHEAD PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
94% fund support · no official result
The 266 asset managers below cast 94% of the shares they voted on this item FOR (78,227,883 for, 5,155,014 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 14,391,383 | 793 | 0 | 0 | For |
| Vanguard | 12,303,757 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 9,936,434 | 0 | 0 | 0 | For |
| Fidelity | 9,216,028 | 0 | 0 | 0 | For |
| State Street | 7,733,619 | 0 | 0 | 0 | For |
| Slate Path Capital LP | 4,644,458 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,272,155 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,920,995 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 2,549,219 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 2,035,512 | 0 | 0 | Against |
| Northern Trust | 1,192,381 | 0 | 0 | 0 | For |
| Aberdeen | 1,048,304 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 656,331 | 0 | 0 | 0 | For |
| Equitable | 498,058 | 0 | 0 | 0 | For |
| UBS | 0 | 373,984 | 0 | 0 | Against |
| Woodline Partners LP | 339,441 | 0 | 0 | 0 | For |
| Nuveen | 315,978 | 0 | 0 | 0 | For |
| TIAA | 306,112 | 0 | 0 | 0 | For |
| Russell Investments | 0 | 293,081 | 0 | 0 | Against |
| PRINCIPAL GLOBAL INVESTORS | 291,859 | 0 | 0 | 0 | For |
| AllianceBernstein | 264,641 | 0 | 0 | 0 | For |
| Hound Partners, LLC | 262,411 | 0 | 0 | 0 | For |
| John Hancock | 261,791 | 0 | 0 | 0 | For |
| Capital Group | 1 | 252,460 | 0 | 0 | Against |
| BANK OF AMERICA NA | 0 | 247,841 | 0 | 0 | Against |
Showing the 25 largest of 266 asset managers. See all 266 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% fund support · no official result
The 265 asset managers below cast 99.9% of the shares they voted on this item FOR (500,637 for, 50 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 0 | 1 Year |
| Vanguard | 0 | 0 | 0 | 0 | One Year |
| Avoro Capital Advisors LLC | 0 | 0 | 0 | 0 | 1 Year |
| Fidelity | 0 | 0 | 0 | 0 | One Year |
| State Street | 0 | 0 | 0 | 0 | One Year |
| Slate Path Capital LP | 0 | 0 | 0 | 0 | One Year |
| T. Rowe Price | 0 | 0 | 0 | 0 | One Year |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | One Year |
| Siren, L.L.C. | 0 | 0 | 0 | 0 | 1 Year |
| Charles Schwab | 0 | 0 | 0 | 0 | 1 Year |
| Northern Trust | 0 | 0 | 0 | 0 | 1 Year |
| Aberdeen | 0 | 0 | 0 | 0 | One Year |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | One Year |
| Equitable | 0 | 0 | 0 | 0 | One Year |
| UBS | 0 | 0 | 0 | 0 | One Year |
| Woodline Partners LP | 0 | 0 | 0 | 0 | One Year |
| Nuveen | 0 | 0 | 0 | 0 | One Year |
| TIAA | 0 | 0 | 0 | 0 | One Year |
| Russell Investments | 0 | 0 | 0 | 0 | 1 Year |
| PRINCIPAL GLOBAL INVESTORS | 0 | 0 | 0 | 0 | One Year |
| AllianceBernstein | 0 | 0 | 0 | 0 | One Year |
| Hound Partners, LLC | 0 | 0 | 0 | 0 | One Year |
| John Hancock | 0 | 0 | 0 | 0 | One Year |
| Capital Group | 0 | 0 | 0 | 0 | 1Yr |
| BANK OF AMERICA NA | 0 | 0 | 0 | 0 | 1 Year |
Showing the 25 largest of 265 asset managers. See all 265 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Adeoye Olukoton”): 80,519,828 for, 2,219,988 against, per its Form 8-K filed 2025-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 125,572,000 outstanding shares: 64% for, 2% against (66% of the company cast a for/against vote).
The 73 asset managers below cast 99.9% of the shares they voted on this item FOR (36,057,403 for, 30,403 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,843,046 | 0 | 0 | 0 | For |
| BlackRock | 9,583,164 | 0 | 0 | 0 | For |
| Fidelity | 5,184,815 | 0 | 0 | 0 | For |
| State Street | 2,298,415 | 535 | 0 | 0 | For |
| T. Rowe Price | 1,666,350 | 0 | 0 | 0 | For |
| Charles Schwab | 1,017,734 | 0 | 0 | 0 | For |
| Aberdeen | 524,152 | 0 | 0 | 0 | For |
| Equitable | 498,058 | 0 | 0 | 0 | For |
| TIAA | 306,112 | 0 | 0 | 0 | For |
| Global X | 218,573 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 198,129 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 164,894 | 0 | 0 | 0 | For |
| Jackson National | 145,298 | 0 | 0 | 0 | For |
| Northern Trust | 143,506 | 0 | 0 | 0 | For |
| Lincoln Financial | 132,045 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,562 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 126,510 | 0 | 0 | 0 | For |
| Capital Group | 126,230 | 0 | 0 | 0 | For |
| JPMorgan | 125,633 | 0 | 0 | 0 | For |
| John Hancock | 124,179 | 0 | 0 | 0 | For |
| Russell Investments | 123,922 | 0 | 0 | 0 | For |
| Brighthouse | 67,669 | 0 | 34,646 | 0 | For |
| Northwestern Mutual | 97,780 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 75,854 | 0 | 0 | 0 | For |
| ProShares | 73,171 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.
Combines 2 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Christopher Anzalone”): 78,346,448 for, 4,406,009 against, per its Form 8-K filed 2025-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 125,572,000 outstanding shares: 62% for, 4% against (66% of the company cast a for/against vote).
The 73 asset managers below cast 99.7% of the shares they voted on this item FOR (35,994,818 for, 92,988 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,843,046 | 0 | 0 | 0 | For |
| BlackRock | 9,583,164 | 0 | 0 | 0 | For |
| Fidelity | 5,184,815 | 0 | 0 | 0 | For |
| State Street | 2,298,615 | 335 | 0 | 0 | For |
| T. Rowe Price | 1,666,350 | 0 | 0 | 0 | For |
| Charles Schwab | 1,017,734 | 0 | 0 | 0 | For |
| Aberdeen | 524,152 | 0 | 0 | 0 | For |
| Equitable | 498,058 | 0 | 0 | 0 | For |
| TIAA | 306,112 | 0 | 0 | 0 | For |
| Global X | 218,573 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 198,129 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 164,894 | 0 | 0 | 0 | For |
| Jackson National | 145,298 | 0 | 0 | 0 | For |
| Northern Trust | 143,506 | 0 | 0 | 0 | For |
| Lincoln Financial | 132,045 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,562 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 126,510 | 0 | 0 | 0 | For |
| Capital Group | 126,230 | 0 | 0 | 0 | For |
| JPMorgan | 125,633 | 0 | 0 | 0 | For |
| John Hancock | 124,179 | 0 | 0 | 0 | For |
| Russell Investments | 123,922 | 0 | 0 | 0 | For |
| Brighthouse | 67,669 | 0 | 34,646 | 0 | For |
| Northwestern Mutual | 97,780 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 75,854 | 0 | 0 | 0 | For |
| ProShares | 73,171 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.
Combines 2 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Douglas Ingram”): 68,899,124 for, 13,843,071 against, per its Form 8-K filed 2025-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 125,572,000 outstanding shares: 54.9% for, 11% against (66% of the company cast a for/against vote).
The 73 asset managers below cast 83% of the shares they voted on this item FOR (29,887,616 for, 6,200,190 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,843,046 | 0 | 0 | 0 | For |
| BlackRock | 9,583,164 | 0 | 0 | 0 | For |
| Fidelity | 5,184,815 | 0 | 0 | 0 | For |
| State Street | 3,964 | 2,294,986 | 0 | 0 | Against |
| T. Rowe Price | 0 | 1,666,350 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,017,734 | 0 | 0 | Against |
| Aberdeen | 524,152 | 0 | 0 | 0 | For |
| Equitable | 234,264 | 263,794 | 0 | 0 | Against |
| TIAA | 306,112 | 0 | 0 | 0 | For |
| Global X | 0 | 218,573 | 0 | 0 | Against |
| AIG/SunAmerica | 198,129 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 164,894 | 0 | 0 | 0 | For |
| Jackson National | 145,298 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 143,506 | 0 | 0 | Against |
| Lincoln Financial | 5,694 | 126,351 | 0 | 0 | Against |
| Columbia Threadneedle | 126,562 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 126,510 | 0 | 0 | 0 | For |
| Capital Group | 126,230 | 0 | 0 | 0 | For |
| JPMorgan | 125,633 | 0 | 0 | 0 | For |
| John Hancock | 116,179 | 8,000 | 0 | 0 | For |
| Russell Investments | 0 | 123,922 | 0 | 0 | Against |
| Brighthouse | 67,669 | 0 | 34,646 | 0 | For |
| Northwestern Mutual | 0 | 97,780 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 75,854 | 0 | 0 | 0 | For |
| ProShares | 73,171 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Hongbo Lu”): 81,171,464 for, 1,552,680 against, per its Form 8-K filed 2025-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 125,572,000 outstanding shares: 65% for, 1% against (66% of the company cast a for/against vote).
The 73 asset managers below cast 99.8% of the shares they voted on this item FOR (36,034,356 for, 53,450 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,843,046 | 0 | 0 | 0 | For |
| BlackRock | 9,583,164 | 0 | 0 | 0 | For |
| Fidelity | 5,184,815 | 0 | 0 | 0 | For |
| State Street | 2,298,415 | 535 | 0 | 0 | For |
| T. Rowe Price | 1,666,350 | 0 | 0 | 0 | For |
| Charles Schwab | 1,017,734 | 0 | 0 | 0 | For |
| Aberdeen | 524,152 | 0 | 0 | 0 | For |
| Equitable | 498,058 | 0 | 0 | 0 | For |
| TIAA | 306,112 | 0 | 0 | 0 | For |
| Global X | 218,573 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 198,129 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 164,894 | 0 | 0 | 0 | For |
| Jackson National | 145,298 | 0 | 0 | 0 | For |
| Northern Trust | 143,506 | 0 | 0 | 0 | For |
| Lincoln Financial | 132,045 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,562 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 126,510 | 0 | 0 | 0 | For |
| Capital Group | 126,230 | 0 | 0 | 0 | For |
| JPMorgan | 125,633 | 0 | 0 | 0 | For |
| John Hancock | 124,179 | 0 | 0 | 0 | For |
| Russell Investments | 123,922 | 0 | 0 | 0 | For |
| Brighthouse | 67,669 | 0 | 34,646 | 0 | For |
| Northwestern Mutual | 97,780 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 75,854 | 0 | 0 | 0 | For |
| ProShares | 73,171 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mauro Ferrari”): 80,079,870 for, 2,649,068 against, per its Form 8-K filed 2025-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 125,572,000 outstanding shares: 64% for, 2% against (66% of the company cast a for/against vote).
The 73 asset managers below cast 99.6% of the shares they voted on this item FOR (35,968,496 for, 119,310 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,843,046 | 0 | 0 | 0 | For |
| BlackRock | 9,583,164 | 0 | 0 | 0 | For |
| Fidelity | 5,184,815 | 0 | 0 | 0 | For |
| State Street | 2,298,166 | 784 | 0 | 0 | For |
| T. Rowe Price | 1,666,350 | 0 | 0 | 0 | For |
| Charles Schwab | 1,017,734 | 0 | 0 | 0 | For |
| Aberdeen | 524,152 | 0 | 0 | 0 | For |
| Equitable | 498,058 | 0 | 0 | 0 | For |
| TIAA | 306,112 | 0 | 0 | 0 | For |
| Global X | 218,573 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 198,129 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 164,894 | 0 | 0 | 0 | For |
| Jackson National | 145,298 | 0 | 0 | 0 | For |
| Northern Trust | 143,506 | 0 | 0 | 0 | For |
| Lincoln Financial | 132,045 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,562 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 126,510 | 0 | 0 | 0 | For |
| Capital Group | 126,230 | 0 | 0 | 0 | For |
| JPMorgan | 125,633 | 0 | 0 | 0 | For |
| John Hancock | 124,179 | 0 | 0 | 0 | For |
| Russell Investments | 123,922 | 0 | 0 | 0 | For |
| Brighthouse | 67,669 | 0 | 34,646 | 0 | For |
| Northwestern Mutual | 97,780 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 75,854 | 0 | 0 | 0 | For |
| ProShares | 73,171 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Michael Perry”): 80,137,421 for, 2,594,224 against, per its Form 8-K filed 2025-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 125,572,000 outstanding shares: 64% for, 2% against (66% of the company cast a for/against vote).
The 73 asset managers below cast 99.8% of the shares they voted on this item FOR (36,034,107 for, 53,699 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,843,046 | 0 | 0 | 0 | For |
| BlackRock | 9,583,164 | 0 | 0 | 0 | For |
| Fidelity | 5,184,815 | 0 | 0 | 0 | For |
| State Street | 2,298,166 | 784 | 0 | 0 | For |
| T. Rowe Price | 1,666,350 | 0 | 0 | 0 | For |
| Charles Schwab | 1,017,734 | 0 | 0 | 0 | For |
| Aberdeen | 524,152 | 0 | 0 | 0 | For |
| Equitable | 498,058 | 0 | 0 | 0 | For |
| TIAA | 306,112 | 0 | 0 | 0 | For |
| Global X | 218,573 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 198,129 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 164,894 | 0 | 0 | 0 | For |
| Jackson National | 145,298 | 0 | 0 | 0 | For |
| Northern Trust | 143,506 | 0 | 0 | 0 | For |
| Lincoln Financial | 132,045 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,562 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 126,510 | 0 | 0 | 0 | For |
| Capital Group | 126,230 | 0 | 0 | 0 | For |
| JPMorgan | 125,633 | 0 | 0 | 0 | For |
| John Hancock | 124,179 | 0 | 0 | 0 | For |
| Russell Investments | 123,922 | 0 | 0 | 0 | For |
| Brighthouse | 67,669 | 0 | 34,646 | 0 | For |
| Northwestern Mutual | 97,780 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 75,854 | 0 | 0 | 0 | For |
| ProShares | 73,171 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Victoria Vakiener”): 80,629,562 for, 2,087,405 against, per its Form 8-K filed 2025-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 125,572,000 outstanding shares: 64% for, 2% against (66% of the company cast a for/against vote).
The 73 asset managers below cast 99.8% of the shares they voted on this item FOR (36,019,409 for, 64,402 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,843,046 | 0 | 0 | 0 | For |
| BlackRock | 9,583,164 | 0 | 0 | 0 | For |
| Fidelity | 5,184,815 | 0 | 0 | 0 | For |
| State Street | 2,298,415 | 535 | 0 | 0 | For |
| T. Rowe Price | 1,666,350 | 0 | 0 | 0 | For |
| Charles Schwab | 1,017,734 | 0 | 0 | 0 | For |
| Aberdeen | 524,152 | 0 | 0 | 0 | For |
| Equitable | 498,058 | 0 | 0 | 0 | For |
| TIAA | 306,112 | 0 | 0 | 0 | For |
| Global X | 218,573 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 198,129 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 164,894 | 0 | 0 | 0 | For |
| Jackson National | 145,298 | 0 | 0 | 0 | For |
| Northern Trust | 143,506 | 0 | 0 | 0 | For |
| Lincoln Financial | 132,045 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,562 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 126,510 | 0 | 0 | 0 | For |
| Capital Group | 126,230 | 0 | 0 | 0 | For |
| JPMorgan | 125,633 | 0 | 0 | 0 | For |
| John Hancock | 124,179 | 0 | 0 | 0 | For |
| Russell Investments | 123,922 | 0 | 0 | 0 | For |
| Brighthouse | 67,669 | 0 | 34,646 | 0 | For |
| Northwestern Mutual | 97,780 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 75,854 | 0 | 0 | 0 | For |
| ProShares | 73,171 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.
Combines 2 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: William Waddill”): 74,963,684 for, 7,769,128 against, per its Form 8-K filed 2025-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 125,572,000 outstanding shares: 60% for, 6% against (66% of the company cast a for/against vote).
The 73 asset managers below cast 93% of the shares they voted on this item FOR (33,581,505 for, 2,506,301 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,843,046 | 0 | 0 | 0 | For |
| BlackRock | 9,583,164 | 0 | 0 | 0 | For |
| Fidelity | 5,184,815 | 0 | 0 | 0 | For |
| State Street | 3,678 | 2,295,272 | 0 | 0 | Against |
| T. Rowe Price | 1,666,350 | 0 | 0 | 0 | For |
| Charles Schwab | 1,017,734 | 0 | 0 | 0 | For |
| Aberdeen | 524,152 | 0 | 0 | 0 | For |
| Equitable | 498,058 | 0 | 0 | 0 | For |
| TIAA | 306,112 | 0 | 0 | 0 | For |
| Global X | 218,573 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 198,129 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 164,894 | 0 | 0 | 0 | For |
| Jackson National | 145,298 | 0 | 0 | 0 | For |
| Northern Trust | 143,506 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,694 | 126,351 | 0 | 0 | Against |
| Columbia Threadneedle | 126,562 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 126,510 | 0 | 0 | 0 | For |
| Capital Group | 126,230 | 0 | 0 | 0 | For |
| JPMorgan | 125,633 | 0 | 0 | 0 | For |
| John Hancock | 124,179 | 0 | 0 | 0 | For |
| Russell Investments | 123,922 | 0 | 0 | 0 | For |
| Brighthouse | 67,669 | 0 | 34,646 | 0 | For |
| Northwestern Mutual | 97,780 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 75,854 | 0 | 0 | 0 | For |
| ProShares | 73,171 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.
100% fund support · no official result
The 70 asset managers below cast 100% of the shares they voted on this item FOR (36,014,872 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,843,046 | 0 | 0 | 0 | For |
| BlackRock | 9,583,164 | 0 | 0 | 0 | For |
| Fidelity | 5,184,815 | 0 | 0 | 0 | For |
| State Street | 2,298,950 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,666,350 | 0 | 0 | 0 | For |
| Charles Schwab | 1,017,734 | 0 | 0 | 0 | For |
| Aberdeen | 524,152 | 0 | 0 | 0 | For |
| Equitable | 498,058 | 0 | 0 | 0 | For |
| TIAA | 306,112 | 0 | 0 | 0 | For |
| Global X | 218,573 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 198,129 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 164,894 | 0 | 0 | 0 | For |
| Jackson National | 145,298 | 0 | 0 | 0 | For |
| Northern Trust | 143,506 | 0 | 0 | 0 | For |
| Lincoln Financial | 132,045 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 126,562 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 126,510 | 0 | 0 | 0 | For |
| Capital Group | 126,230 | 0 | 0 | 0 | For |
| JPMorgan | 125,633 | 0 | 0 | 0 | For |
| John Hancock | 124,179 | 0 | 0 | 0 | For |
| Russell Investments | 123,922 | 0 | 0 | 0 | For |
| Brighthouse | 67,669 | 0 | 34,646 | 0 | For |
| Northwestern Mutual | 97,780 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 75,854 | 0 | 0 | 0 | For |
| ProShares | 73,171 | 0 | 0 | 0 | For |
Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.
Combines 2 wordings of this item as funds reported it.
26% fund support · no official result
The 11 asset managers below cast 26% of the shares they voted on this item FOR (209,203 for, 594,834 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 0 | 591,396 | 0 | 0 | Against |
| NORDEA INVESTMENT MANAGEMENT AB | 131,750 | 0 | 0 | 0 | For |
| Empower | 70,486 | 0 | 0 | 0 | For |
| Maj Invest Holding A/S | 4,377 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 2,416 | 0 | 0 | 0 | For |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 0 | 2,350 | 0 | 0 | Against |
| Desjardins Global Asset Management Inc. | 0 | 1,033 | 0 | 0 | Against |
| Uniplan Investment Counsel, Inc. | 117 | 0 | 0 | 0 | For |
| Athena Investment Management | 0 | 55 | 0 | 0 | Against |
| UNIFIED SERIES TRUST | 32 | 0 | 0 | 0 | For |
| Coyle Financial Counsel LLC | 25 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 10 asset managers below cast 100% of the shares they voted on this item FOR (132,550 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 0 | 0 | 0 | 0 | One Year |
| NORDEA INVESTMENT MANAGEMENT AB | 131,750 | 0 | 0 | 0 | For |
| Empower | 0 | 0 | 0 | 0 | One Year |
| Maj Invest Holding A/S | 0 | 0 | 4,377 | 0 | Abstain |
| HC CAPITAL TRUST | 0 | 0 | 0 | 0 | One Year |
| Desjardins Global Asset Management Inc. | 0 | 0 | 0 | 0 | One Year |
| PRINCETON CAPITAL MANAGEMENT LLC | 800 | 0 | 0 | 0 | For |
| Uniplan Investment Counsel, Inc. | 0 | 0 | 0 | 0 | 1 Year |
| UNIFIED SERIES TRUST | 0 | 0 | 0 | 0 | One Year |
| Coyle Financial Counsel LLC | 0 | 0 | 0 | 0 | 1 Year |
99.4% fund support · no official result
The 3 asset managers below cast 99.4% of the shares they voted on this item FOR (226,513 for, 1,163 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rhumbline | 159,113 | 0 | 0 | 0 | For |
| M28 Capital Management LP | 67,400 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 0 | 1,163 | 0 | 0 | Against |
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR (72,934 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 70,486 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 2,416 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 32 | 0 | 0 | 0 | For |
Showing the 15 reported items with the widest manager coverage, of 17 in total. View every item.
Ranked by the number of ARROWHEAD PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 125,572,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 11.46% |
| 2 | Vanguard | 9.80% |
| 3 | Avoro Capital Advisors LLC | 7.91% |
| 4 | Fidelity | 7.34% |
| 5 | State Street | 6.16% |
| 6 | Slate Path Capital LP | 3.70% |
| 7 | T. Rowe Price | 3.40% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.33% |
| 9 | Siren, L.L.C. | 2.03% |
| 10 | Charles Schwab | 1.62% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 15.87% | 13F |
| Vanguard Group | 10.51% | 13F |
| Avoro Capital Advisors LLC | 7.08% | DEF14A |
| Vanguard Portfolio Management | 5.79% | 13G |
| State Street | 5.57% | 13F |
| Christopher Anzalone | 3.00% | DEF14A |
| FMR (Fidelity) | 2.64% | 13F |
| Morgan Stanley | 1.47% | 13F |
| Goldman Sachs | 1.39% | 13F |
| Norges Bank | 1.33% | 13F |
Percentages above are of 125,572,000 shares outstanding, as reported by ARROWHEAD PHARMACEUTICALS INC. on its Form 10-Q dated 2024-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ARROWHEAD PHARMACEUTICALS INC.’s 10-Q dated 2024-12-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At ARROWHEAD PHARMACEUTICALS INC.'s shareholder meeting held 2025-03-12, in the 2024-2025 proxy season, 289 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,498 separate fund positions. Their filings are grouped here into 17 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. ARROWHEAD PHARMACEUTICALS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Advisory vote to approve named executive officer compensation. — the reporting funds cast 94% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
ARROWHEAD PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.